Gynopedia needs your support! Please consider contributing content, translating a page, or making a donation today. With your support, we can sustain and expand the website. Gynopedia has no corporate sponsors or advertisers. Your support is crucial and deeply appreciated.
All translations
Jump to navigation
Jump to search
Enter a message name below to show all available translations.
Found one translation.
| Name | Current message text |
|---|---|
| h English (en) | Regarding PrEP: "There are three ongoing demonstration projects in Australia—VicPrEP in MSM, transgender women, heterosexual serodiscordant couples and people who received N-PEP on more than two occasions; PRELUDE in men and women at high and ongoing risk of HIV; and EPIC-NSW enrolling high-risk, mostly gay and bisexual men in New South Wales. A fourth demonstration project, PrEPX, will start later this year. The Therapeutic Goods Administration has approved daily oral Truvada for HIV prevention."<ref>[http://www.prepwatch.org/australia/ PrEP Watch: Australia]</ref> |